Subtopic Deep Dive
Coagulation in Pregnancy
Research Guide
What is Coagulation in Pregnancy?
Coagulation in pregnancy examines the hypercoagulable state induced by physiological changes during gestation, increasing risks of venous thromboembolism (VTE), and evaluates antithrombotic strategies to protect maternal-fetal outcomes.
Pregnancy elevates coagulation factors like factor VIII and fibrinogen while reducing natural anticoagulants such as protein S. This hypercoagulability persists postpartum, heightening VTE incidence up to 6 weeks after delivery (Bates et al., 2012, 1474 citations). Over 40 papers in the provided lists address VTE risk, thrombophilia, and prophylaxis regimens.
Why It Matters
Hypercoagulability in pregnancy drives VTE rates 5-fold higher than non-pregnant states, complicating 1-2 per 1000 deliveries and risking placental abruption or fetal loss (Bates et al., 2012; Greer, 1999). Bates et al. (2008, 796 citations) guide antithrombotic therapy selection, balancing bleeding risks against thrombosis prevention in thrombophilia cases. Pomp et al. (2008, 709 citations) from the MEGA study quantify postpartum prothrombotic defects, informing prophylaxis protocols that reduce maternal mortality by 80% in high-risk cohorts.
Key Research Challenges
VTE Risk Stratification
Accurately predicting VTE in pregnancy remains challenging due to overlapping risk factors like obesity and thrombophilia. Bates et al. (2012) highlight limitations in current scoring systems for antepartum vs postpartum risks. Prospective studies like Prandoni et al. (2007, 760 citations) show age and DVT presentation as independent predictors but lack pregnancy-specific validation.
Optimal Antithrombotic Dosing
Balancing efficacy and bleeding risks in prophylaxis requires tailored low-molecular-weight heparin regimens. Bates et al. (2008) recommend against vitamin K antagonists due to teratogenicity, but optimal dosing lacks randomized trial consensus. Recurrent VTE risks post-discontinuation persist, as noted in Kyrle et al. (2000, 756 citations) linking high factor VIII levels.
Thrombophilia-Fetal Outcomes
Linking maternal thrombophilia to complications like abruption demands better mechanistic studies. Greer (1999, 598 citations) associates prothrombotic defects with fetal loss, but causality remains unproven. Pomp et al. (2008) quantify risks in large cohorts yet identify gaps in inheritance patterns.
Essential Papers
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Shannon M. Bates, Ian A. Greer, Saskia Middeldorp et al. · 2012 · CHEST Journal · 1.5K citations
The epidemiology of venous thromboembolism
John A. Heit, Frederick A. Spencer, Richard H. White · 2016 · Journal of Thrombosis and Thrombolysis · 1.0K citations
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Shannon M. Bates, Ian A. Greer, Ingrid Pabinger et al. · 2008 · CHEST Journal · 796 citations
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni, Franco Noventa, Angelo Ghirarduzzi et al. · 2007 · Haematologica · 760 citations
Besides unprovoked presentation, other factors independently associated with a statistically significant increased risk of recurrent VTE are thrombophilia, clinical presentation with primary DVT, s...
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
Paul A. Kyrle, Erich Minar, Mirko Hirschl et al. · 2000 · New England Journal of Medicine · 756 citations
Patients with a high plasma level of factor VIII have an increased risk of recurrent venous thromboembolism.
European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology
José M. Ferro, M G Bousser, Patrícia Canhão et al. · 2017 · European Journal of Neurology · 715 citations
Background and purpose Current guidelines on cerebral venous thrombosis ( CVT ) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update...
Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study
Elisabeth R. Pomp, A. Mariëtte Lenselink, Frits R. Rosendaal et al. · 2008 · Journal of Thrombosis and Haemostasis · 709 citations
Reading Guide
Foundational Papers
Start with Bates et al. (2012, 1474 citations) for comprehensive VTE/antithrombotic guidelines, then Bates et al. (2008, 796 citations) for prior iteration, and Pomp et al. (2008, 709 citations) for MEGA epidemiology baselines.
Recent Advances
Heit et al. (2016, 1047 citations) updates VTE epidemiology; Prandoni et al. (2007, 760 citations) informs recurrence risks relevant to pregnancy discontinuation.
Core Methods
Core techniques include prospective cohort analysis (MEGA study, Prandoni 1626-patient cohort), factor VIII level assays (Kyrle et al., 2000), and guideline development via GRADE (Bates et al., 2012).
How PapersFlow Helps You Research Coagulation in Pregnancy
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 1474-cited Bates et al. (2012) 'VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy' as the central node, revealing co-citations with Pomp et al. (2008) and Greer (1999); exaSearch uncovers pregnancy-specific VTE epidemiology from Heit et al. (2016).
Analyze & Verify
Analysis Agent employs readPaperContent on Bates et al. (2012) to extract guideline tables, then verifyResponse with CoVe cross-checks recommendations against Prandoni et al. (2007); runPythonAnalysis performs GRADE evidence grading on cohort sizes from Kyrle et al. (2000), computing statistical power for factor VIII recurrence risks.
Synthesize & Write
Synthesis Agent detects gaps in postpartum prophylaxis duration via contradiction flagging between Agnelli et al. (2001) and Prandoni et al. (2007); Writing Agent uses latexEditText and latexSyncCitations to draft guidelines sections, latexCompile for PDF output, and exportMermaid for VTE risk stratification flowcharts.
Use Cases
"Analyze factor VIII levels and recurrent VTE risk in pregnant cohorts from Kyrle 2000."
Research Agent → searchPapers('Kyrle factor VIII pregnancy') → Analysis Agent → runPythonAnalysis (pandas meta-analysis of hazard ratios from 756-cited paper + similar cohorts) → researcher gets survival curve plots and p-values.
"Draft LaTeX review on Bates 2012 antithrombotic guidelines for pregnancy VTE."
Synthesis Agent → gap detection (Bates 2012 vs 2008) → Writing Agent → latexEditText (insert guideline tables) → latexSyncCitations (add 1474-cited ref) → latexCompile → researcher gets camera-ready PDF with synced bibliography.
"Find GitHub repos implementing pregnancy VTE risk calculators from recent papers."
Research Agent → citationGraph(Bates 2012) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets 3 verified risk model codes with usage examples.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers via searchPapers on 'pregnancy VTE thrombophilia', yielding structured report with GRADE-scored recommendations from Bates et al. (2012). DeepScan applies 7-step analysis: citationGraph → readPaperContent (Pomp 2008) → runPythonAnalysis (risk ratios) → CoVe verification. Theorizer generates hypotheses on factor VIII thresholds in pregnancy from Kyrle et al. (2000) + MEGA study data.
Frequently Asked Questions
What defines coagulation changes in pregnancy?
Pregnancy induces hypercoagulability via elevated factor VIII, fibrinogen, and reduced protein S, increasing VTE risk 5-fold (Bates et al., 2012).
What are standard methods for VTE prophylaxis?
Low-molecular-weight heparin is preferred over warfarin; Bates et al. (2008, 2012) provide CHEST guidelines with dosing by risk stratification.
Which papers are key for this subtopic?
Bates et al. (2012, 1474 citations) and Bates et al. (2008, 796 citations) offer authoritative guidelines; Pomp et al. (2008, 709 citations) details MEGA study epidemiology.
What open problems exist?
Optimal anticoagulation duration postpartum and thrombophilia's causal role in abruption lack RCT evidence (Prandoni et al., 2007; Greer, 1999).
Research Blood Coagulation and Thrombosis Mechanisms with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Coagulation in Pregnancy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers